Predictive Factors of Portal Vein Thrombus Following Splenectomy in Patients with Severe Cirrhosis

被引:8
|
作者
Iida, Hiroya [1 ]
Aihara, Tsukasa [1 ]
Ikuta, Shinichi [1 ]
Yamanaka, Naoki [1 ]
机构
[1] Meiwa Hosp, Dept Surg, Nishinomiya, Hyogo 6638186, Japan
关键词
anticoagulant; portal vein thrombus; spleen volume; splenectomy; splenic vein thrombus; RISK-FACTORS; SPLENIC VEIN; LAPAROSCOPIC SPLENECTOMY; VENOUS THROMBOSIS;
D O I
10.5754/hge14409
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Splenectomy is performed in patients with severe cirrhosis who have a low platelet count. A portal vein thrombus (PVT) is one of the complications associated with splenectomy. This study aimed to identify predictive factors of postoperative PVT following splenectomy. Methodology: Twenty-eight patients who underwent splenectomy between April 2003 and March 2013 were retrospectively analyzed. Patients were divided into two groups: the PVT(+) group comprising 11 patients who developed postoperative PVT, and the PVT(-) group comprising 17 patients who did not develop postoperative PVT. The patient characteristics of the 2 groups were analyzed. Results: In univariate analysis, the platelet count, rate of-simultaneous-treatment-of-hepatocellular-carcinoma, and preoperative spleen volume were significantly different between the groups (p < 0.05). In multivariate analysis, preoperative spleen volume alone was an independent factor associated with the development of PVT (p = 0.007). At a preoperative spleen volume cutoff of 450 mL, the sensitivity and specificity were 90% and 73%, respectively. Conclusion: In patients with severe cirrhosis scheduled to undergo splenectomy, if the preoperative spleen volume is >450 mL, as measured by enhanced computed tomography, preventive administration of anticoagulant therapy is recommended to reduce the risk of PVT development.
引用
收藏
页码:1552 / 1555
页数:4
相关论文
共 50 条
  • [31] Implications of portal vein thrombosis after splenectomy for patients with idiopathic portal hypertension
    Teijiro Hirashita
    Masayuki Ohta
    Seiichiro Kai
    Takashi Masuda
    Hidetoshi Eguchi
    Yukio Iwashita
    Tadashi Ogawa
    Seigo Kitano
    Surgery Today, 2011, 41 : 1475 - 1480
  • [32] Implications of Portal Vein Thrombosis After Splenectomy for Patients with Idiopathic Portal Hypertension
    Hirashita, Teijiro
    Ohta, Masayuki
    Kai, Seiichiro
    Masuda, Takashi
    Eguchi, Hidetoshi
    Iwashita, Yukio
    Ogawa, Tadashi
    Kitano, Seigo
    SURGERY TODAY, 2011, 41 (11) : 1475 - 1480
  • [33] Retrospective study of the incidence of portal vein thrombosis after splenectomy in hematological disorders: Risk factors and clinical presentation
    Sabbagh, Ali
    Keikhaei, Bijan
    Joorabian, Morteza
    Behzad, Masumeh Maleki
    Momeni, Mohammad
    BLOOD CELLS MOLECULES AND DISEASES, 2019, 74 : 1 - 4
  • [34] Predictors of portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection in hepatitis B cirrhosis: a prospective study
    Wu, Long-Fei
    Bai, Dou-Sheng
    Shi, Lin
    Jin, Sheng-Jie
    Zhou, Bao-Huan
    Jiang, Guo-Qing
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2022, 36 (06): : 4090 - 4098
  • [35] A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
    Xiao, Cheng-Zuo
    Wei, Wei
    Guo, Zhi-Xing
    Li, Shu-Hong
    Zhang, Yong-Fa
    Wang, Jia-Hong
    Shi, Ming
    Guo, Rong-Ping
    ONCOLOGY LETTERS, 2015, 10 (05) : 2787 - 2794
  • [36] Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis
    Suda, Tsuyoshi
    Takatori, Hajime
    Hayashi, Takehiro
    Horii, Rika
    Nio, Kouki
    Terashima, Takeshi
    Iida, Noriho
    Kitahara, Masaaki
    Shimakami, Tetsuro
    Arai, Kuniaki
    Yamashita, Taro
    Yamashita, Tatsuya
    Mizukoshi, Eishiro
    Honda, Masao
    Okumura, Kenichiro
    Kozaka, Kazuto
    Kaneko, Shuichi
    LIFE-BASEL, 2020, 10 (09): : 1 - 14
  • [37] Predictive Value of Inflammation Biomarkers in Patients with Portal Vein Thrombosis
    Han, Jian-Bo
    Shu, Qing-Hua
    Zhang, Yu-Feng
    Yi, Yong-Xiang
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (03) : 384 - 391
  • [38] Splenectomy in living donor liver transplantation and risk factors of portal vein thrombosis
    Nobuhiko Kurata
    Yasuhiro Ogura
    Satoshi Ogiso
    Yasuharu Onishi
    Hideya Kamei
    Yasuhiro Kodera
    Hepatobiliary&PancreaticDiseasesInternational, 2019, 18 (04) : 337 - 342
  • [39] Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis
    Wang, Le
    Guo, Xiaozhong
    Xu, Xiangbo
    De Stefano, Valerio
    Plessier, Aurelie
    Ferreira, Carlos Noronha
    Qi, Xingshun
    ADVANCES IN THERAPY, 2021, 38 (01) : 495 - 520
  • [40] Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis
    Le Wang
    Xiaozhong Guo
    Xiangbo Xu
    Valerio De Stefano
    Aurelie Plessier
    Carlos Noronha Ferreira
    Xingshun Qi
    Advances in Therapy, 2021, 38 : 495 - 520